Related references
Note: Only part of the references are listed.The proliferation of human mucosal-associated invariant T cells requires a MYC-SLC7A5-glycolysis metabolic axis
Nidhi Kedia-Mehta et al.
SCIENCE SIGNALING (2023)
Hippo/YAP signaling choreographs the tumor immune microenvironment to promote triple negative breast cancer progression via TAZ/IL-34 axis
Zheng Wang et al.
CANCER LETTERS (2022)
The hallmarks of cancer metabolism: Still emerging
Natalya N. Pavlova et al.
CELL METABOLISM (2022)
SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen-receptor-positive breast cancer
Rasmus Tornroos et al.
ONCOLOGY REPORTS (2022)
Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
Sasagu Kurozumi et al.
SCIENTIFIC REPORTS (2022)
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics
Yoshikatsu Kanai
PHARMACOLOGY & THERAPEUTICS (2022)
CircRNA DDX21 acts as a prognostic factor and sponge of miR-1264/QKI axis to weaken the progression of triple-negative breast cancer
Renhong Huang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer
Qizhi Wang et al.
PHARMACOLOGICAL RESEARCH (2022)
Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
Marianna Nachef et al.
FRONTIERS IN IMMUNOLOGY (2021)
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy
Wen-Hsuan Yang et al.
TRENDS IN CANCER (2021)
Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy
Weimin Wang et al.
MOLECULAR CELL (2020)
Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity
Jun-Kyu Byun et al.
MOLECULAR CELL (2020)
A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer
Zheng Wang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Dongqiang Zeng et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The L-Type Amino Acid Transporter LAT1An Emerging Target in Cancer
Pascal Hafliger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer
Yasuhiro Saito et al.
NATURE (2019)
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
Michael L. Schulte et al.
NATURE MEDICINE (2018)
The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
Rokaya El Ansari et al.
BREAST CANCER RESEARCH (2018)
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition
Michael Lampa et al.
PLOS ONE (2017)
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Ji Zhang et al.
EMBO JOURNAL (2017)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes
Tonje H. Haukaas et al.
CANCER & METABOLISM (2016)
Famine versus feast: understanding the metabolism of tumors in vivo
Jared R. Mayers et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia
C. Rosilio et al.
LEUKEMIA (2015)
Metabolic characterization of triple negative breast cancer
Maria D. Cao et al.
BMC CANCER (2014)
Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation (vol 14, pg 500, 2013)
Linda V. Sinclair et al.
NATURE IMMUNOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Leucine nutrition in animals and humans: mTOR signaling and beyond
Fengna Li et al.
AMINO ACIDS (2011)
Glutamine Synthetase Is a Genetic Determinant of Cell Type-Specific Glutamine Independence in Breast Epithelia
Hsiu-Ni Kung et al.
PLOS GENETICS (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
Koji Oda et al.
CANCER SCIENCE (2010)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Share Paper
